{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:52:43Z","timestamp":1772358763948,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107092"],"award-info":[{"award-number":["22107092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117286","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T21:41:35Z","timestamp":1737150095000},"page":"117286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents"],"prefix":"10.1016","volume":"286","author":[{"given":"Zi-Jie","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117286_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/14756366.2017.1396455","article-title":"New pentadienone oxime ester derivatives: synthesis and anti-inflammatory activity","volume":"33","author":"Li","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112932","article-title":"Synthesis and anti-inflammatory activity of saponin derivatives of \u03b4-oleanolic acid","volume":"209","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127838","article-title":"The role of intestinal microbiota and metabolites in intestinal inflammation","volume":"288","author":"Ma","year":"2024","journal-title":"Microbiol. Res."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117286_bib4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.apsb.2022.07.009","article-title":"Self-therapeutic metal-based nanoparticles for treating inflammatory diseases","volume":"13","author":"Han","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117286_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116259","article-title":"Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: an update","volume":"228","author":"Chun","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejmech.2025.117286_bib6","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.3390\/ijms25189864","article-title":"The regulatory roles of inflammation and inflammasomes in liver diseases","volume":"25","author":"Yi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117286_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115973","article-title":"Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases","volume":"220","author":"Wang","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117286_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13284","article-title":"Inflammation-Dysregulated inflammatory response and strategies for treatment","volume":"226","author":"Herold","year":"2019","journal-title":"Acta Physiol (Oxf)"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117286_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.17305\/bb.2023.9997","article-title":"The roles of ubiquitination and deubiquitination of NLRP3 inflammasome in inflammation-related diseases: a review","volume":"24","author":"Tang","year":"2024","journal-title":"Biomol. Biomed."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117286_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ajhb.24042","article-title":"Hypoxia, NSAIDs, and autism: a biocultural analysis of stressors in gametogenesis","volume":"36","author":"Burke","year":"2024","journal-title":"Am. J. Hum. Biol."},{"key":"10.1016\/j.ejmech.2025.117286_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108327","article-title":"Interactions between NSAIDs, opioids and the gut microbiota - future perspectives in the management of inflammation and pain","volume":"241","author":"Z\u00e1dori","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117286_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.31925\/farmacia.2024.1.3","article-title":"NON-STEROIDAL anti-inflammatory drugs (nsaids) as repurposed anticancer drugs IN SKIN cancer","volume":"72","author":"Iftode","year":"2024","journal-title":"FARMACIA"},{"key":"10.1016\/j.ejmech.2025.117286_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113682","article-title":"Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential","volume":"224","author":"Said","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117899","article-title":"Design, classification, and adverse effects of NSAIDs: a review on recent advancements","volume":"112","author":"Arfeen","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117286_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117286_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105557","article-title":"Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates","volume":"119","author":"Ghanim","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bioorg.2017.06.003","article-title":"New 1,3,4-oxadiazole\/oxime hybrids: design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability","volume":"74","author":"Abd-Ellah","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111259","article-title":"Synthesis, characterization, computational assay and anti-inflammatory activity of thiosemicarbazone derivatives: highly potent and efficacious for COX inhibitors","volume":"126","author":"Saeed","year":"2024","journal-title":"Int. Immunopharm."},{"issue":"42","key":"10.1016\/j.ejmech.2025.117286_bib19","doi-asserted-by":"crossref","first-page":"30647","DOI":"10.1039\/D4RA04686B","article-title":"NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead","volume":"14","author":"Khalil","year":"2024","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117286_bib20","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11095-023-03571-4","article-title":"Challenges and opportunities for celecoxib repurposing","volume":"40","author":"B\u0105k","year":"2023","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2025.117286_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104610","article-title":"Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme","volume":"107","author":"El-Dash","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bioorg.2016.12.008","article-title":"Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"70","author":"Alsayed","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105485","article-title":"Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids","volume":"119","author":"Felipe","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115496","article-title":"Synthesis and anti-inflammatory activity evaluation of NO-releasing furoxan\/1,2,4-triazole hybrid derivatives","volume":"257","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2014.02.033","article-title":"Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents","volume":"76","author":"Hassan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117286_bib26","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s10753-022-01690-5","article-title":"Neutrophil-derived COX-2 has a key role during inflammatory hyperalgesia","volume":"45","author":"Carvalho","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2025.117286_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.891484","article-title":"Synthesis methods of 1,2,3-\/1,2,4-triazoles: a review","volume":"10","author":"Dai","year":"2022","journal-title":"Front. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117286_bib28","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.bmcl.2015.04.079","article-title":"Synthesis and anti-inflammatory activity of new 1,2,4-triazole derivatives","volume":"25","author":"Paprocka","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117286_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115655","article-title":"Recent advances in triazoles as tyrosinase inhibitors","volume":"259","author":"Mermer","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115697","article-title":"Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK\/NF-\u03baB\/NLRP3 pathway","volume":"259","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117286_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104226","article-title":"Design, synthesis, biological evaluation and in silico studies of novel 1,2,3-triazole linked benzoxazine-2,4-dione conjugates as potent antimicrobial, antioxidant and anti-inflammatory agents","volume":"15","author":"Hammouda","year":"2022","journal-title":"Arab. J. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117286_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/D1MD00280E","article-title":"Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors","volume":"13","author":"Ahmadi","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107348","article-title":"Design, molecular docking analysis of an anti-inflammatory drug, computational analysis and intermolecular interactions energy studies of 1-benzothiophene-2-carboxylic acid","volume":"88","author":"Sagaama","year":"2020","journal-title":"Comput. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117286_bib34","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/ejic.201500050","article-title":"Synthesis, crystal structures, molecular docking, and urease inhibitory activities of transition-metal complexes with a 1,2,4-triazolecarboxylic acid derived ligand","author":"Xu","year":"2015","journal-title":"Eur. J. Inorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117286_bib35","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1189\/jlb.0310149","article-title":"The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation","volume":"88","author":"Kobayashi","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2025.117286_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112216","article-title":"Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation","volume":"193","author":"Yang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117286_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3858\/emm.2009.41.9.069","article-title":"Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated RAW 264.7 cells","volume":"41","author":"Lee","year":"2009","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117286_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00281-012-0342-8","article-title":"Multifaceted roles of PGE2 in inflammation and cancer","volume":"35","author":"Nakanishi","year":"2013","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117286_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biocel.2009.09.015","article-title":"Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances","volume":"42","author":"Legler","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117286_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejmech.2018.07.054","article-title":"Novel hydrazido benzenesulfonamides-isatin conjugates: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"157","author":"Abo-Ashour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117286_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126874","article-title":"Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors","volume":"30","author":"Yang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117286_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104259","article-title":"Screening cyclooxygenase-2 inhibitors from Andrographis paniculata to treat inflammation based on bio-affinity ultrafiltration coupled with UPLC-Q-TOF-MS","volume":"137","author":"Jiao","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.117286_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112181","article-title":"An experimental study of the anti-dysmenorrhea effect of Chinese herbal medicines used in Jin Gui Yao Lue","volume":"245","author":"Li","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117286_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14756366.2021.1908277","article-title":"Utility of novel 2-furanones in synthesis of other heterocyclic compounds having anti-inflammatory activity with dual COX2\/LOX inhibition","volume":"36","author":"Abd El-Hameed","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117286_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115549","article-title":"Synthesis of novel 3,5,6-trisubstituted 2-pyridone derivatives and evaluation for their anti-inflammatory activity","volume":"28","author":"Gon\u00e7alves","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117286_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153173","article-title":"Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-\u03baB and STAT3 pathways","volume":"68","author":"Wu","year":"2020","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117286_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2024.101815","article-title":"Structure\u2013Activity relationship (SAR) of 18\u03b2-glycyrrhetinic acid derivatives on their antitumor activity through the PPAR\u03b3 receptor and caspase-3 pathway","volume":"28","author":"Sun","year":"2024","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117286_bib48","series-title":"Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.ejmech.2025.117286_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125755","article-title":"Exploring protein-berberine interactions via molecular dynamics and MM\/GBSA calculations","volume":"411","author":"Li","year":"2024","journal-title":"J. Mol. Liq."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:00:32Z","timestamp":1740373232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"alternative-id":["S0223523425000510"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117286","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117286"}}